StockData
Processa Pharmaceuticals, Inc. logo

Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.70−0.03 (-1.73%)

Close on Nov 18, 2026Market cap $4.75MP/E –Yield –

Processa Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Processa Pharmaceuticals's price to sales ratio was 273.8× on Jan 31, 2017.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2017Jan 31, 2017273.8×−179.5
2016Dec 30, 2016453.3×−41.0
2015Nov 30, 2015494.3×–

More Processa Pharmaceuticals figures

See a number that looks wrong?